| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
First Department of Surgery, Yamanashi Medical University, Yamanashi 409-3898, Japan
To evaluate the mechanisms of T-cell dysfunction in patients with
gastric cancer, we investigated the caspase activity of T cells, the
induction of spontaneous T-cell apoptosis, the expression of T-cell
receptor (TCR)
molecules, and the ability of T cells to produce
cytokines in peripheral blood lymphocytes from patients
(n = 22) and healthy controls
(n = 14). The caspase-3 activity of T cells was
studied as the protease activity of caspase-3 using the cell-permeable
substrate of PhiPhiLux G1D2. Flow cytometric analysis was performed
with triple staining by annexin V-FITC, propidium iodide, and
CD3-R-phycoerythrin-Cy5 for the detection of T-cell apoptosis
and with intracellular staining using permeabilized cells for the
expression of TCR-
molecules. IFN-
and tumor necrosis
factor
production from T cells was evaluated in response to
anti-CD3 stimulation. Caspase-3 activity of peripheral blood T cells
from patients with advanced disease was significantly increased
compared with that from controls [15.5 ± 3.6 mean fluorescence
intensity (MFI) versus 11.5 ± 3.3 MFI;
P = 0.0068]. Parallel to this, the apoptosis of
peripheral blood T cells from patients with advanced disease was
significantly higher than for those from controls (16.5 ± 15.5%
versus 4.8 ± 2.7%; P =
0.010). Furthermore, the expression of TCR-
molecules in patients
with advanced disease was significantly decreased in comparison with
that of the controls (41.0 ± 13.9 MFI versus
56.7 ± 16.3 MFI; P = 0.014), and this
decreased expression coexisted with impaired IFN-
(42.4 ± 43.2
pg/ml versus 1757.4 ± 2449.0 pg/ml;
P = 0.031) and tumor necrosis factor
(682.6 ± 519.3 pg/ml versus 1686.0 ± 1533.7
pg/ml; P = 0.041) production of T cells. Thus,
peripheral blood T cells from gastric cancer patients simultaneously
exhibit an elevated caspase-3 activity, an increased degree of T-cell
apoptosis, a down-regulation of TCR-
molecules, and impaired
cytokine production. These observations suggest that induction of
T-cell apoptosis coexisting with a down-regulation of TCR-
molecules
may be responsible for T-cell dysfunction in patients with gastric
cancer.
This article has been cited by other articles:
![]() |
T. Osaki, H. Saito, T. Yoshikawa, S. Matsumoto, S. Tatebe, S. Tsujitani, and M. Ikeguchi Decreased NKG2D Expression on CD8+ T Cell Is Involved in Immune Evasion in Patients with Gastric Cancer Clin. Cancer Res., January 15, 2007; 13(2): 382 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuzaka, K. Nozaki, C. Kumazawa, K. Shiraishi, Y. Setoyama, K. Yoshimoto, K. Suzuki, T. Abe, and T. Takeuchi DNA Microarray Gene Expression Profile of T Cells with the Splice Variants of TCR{zeta} mRNA Observed in Systemic Lupus Erythematosus J. Immunol., January 15, 2006; 176(2): 949 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Parmiani, C. Castelli, and L. Rivoltini Chemokine Receptor 7, A New Player in Regulating Apoptosis of CD8+ T Cells in Cancer Patients Clin. Cancer Res., November 1, 2005; 11(21): 7587 - 7588. [Full Text] [PDF] |
||||
![]() |
S. Krishnan, J. G. Kiang, C. U. Fisher, M. P. Nambiar, H. T. Nguyen, V. C. Kyttaris, B. Chowdhury, V. Rus, and G. C. Tsokos Increased Caspase-3 Expression and Activity Contribute to Reduced CD3{zeta} Expression in Systemic Lupus Erythematosus T Cells J. Immunol., September 1, 2005; 175(5): 3417 - 3423. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, and H. Fujii Increased Populations of Regulatory T Cells in Peripheral Blood and Tumor-Infiltrating Lymphocytes in Patients with Gastric and Esophageal Cancers Clin. Cancer Res., October 1, 2003; 9(12): 4404 - 4408. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-T. Juang, K. Tenbrock, M. P. Nambiar, M. F. Gourley, and G. C. Tsokos Defective Production of Functional 98-kDa Form of Elf-1 Is Responsible for the Decreased Expression of TCR {zeta}-Chain in Patients with Systemic Lupus Erythematosus J. Immunol., November 15, 2002; 169(10): 6048 - 6055. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |